CLINICAL_TRIALS
ClinicalTrials.gov record update
A Double-blinded Crossover Study of Topical Formulation of Nitroglycerine, Vascana®, Versus Matching Vehicle in the Subjective and Physiologic Responses to Controlled Cold Challenge in Subjects With Raynaud's Phenomenon (RP) Secondary to Connective Tissue Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02688270
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:55.920201+00:00
- Published At
- 2022-11-02T00:00:00+00:00
- Record Updated At
- 2022-11-02
- Results Posted At
- 2022-11-02
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Raynaud\u0027s Phenomenon Secondary to Connective Tissue Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-11-02"- protocolSection.identificationModule.nctId
"NCT02688270"- protocolSection.identificationModule.officialTitle
"A Double-blinded Crossover Study of Topical Formulation of Nitroglycerine, Vascana\u00ae, Versus Matching Vehicle in the Subjective and Physiologic Responses to Controlled Cold Challenge in Subjects With Raynaud\u0027s Phenomenon (RP) Secondary to Connective Tissue Disease"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-11-02"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.